Posted by Michael Wonder on 12 Jul 2017
The economics of indication-based drug pricing
12 July 2017 - Contrary to the hopes of its supporters, indication-based drug pricing will result in higher prices for patients who benefit the most from a given drug, higher utilisation by patients who benefit least, higher overall spending, and higher manufacturer profits.
